News
ATAI
7.35
+0.14%
0.01
'New Bill In Congress Would Dramatically Overhaul How The Federal Government Classifies Drugs While Legalizing Marijuana' - Marijuana Moment
Benzinga · 20h ago
Cantor Fitzgerald Suspends Neutral Rating on AtaiBeckley Inc
Benzinga · 09/22 10:55
Weekly Report: what happened at ATAI last week (0907-0911)?
Weekly Report · 09/14 10:17
*News On AtaiBeckley Inc. (ATAI) Now Under LLY
Dow Jones · 09/11 21:08
Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?
NASDAQ · 09/10 15:30
FDA names acting heads of drug and vaccine units to permanent roles
Seeking Alpha · 09/09 00:25
After Hours Most Active for Sep 8, 2026 : ATAI, NU, RIG, NVDA, KO, T, AS, WMT, MRK, HBAN, ON, AAPL
NASDAQ · 09/08 20:29
Lilly Builds Neuroscience into a New Long-Term Growth Driver
NASDAQ · 09/08 12:27
Weekly Report: what happened at ATAI last week (0831-0904)?
Weekly Report · 09/07 10:11
3 things to look out for on Tuesday
Seeking Alpha · 09/04 20:07
Jim Cramer Isn't Sure If There’s Upside In This Health Care Stock
Benzinga · 09/03 11:04
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
Benzinga · 08/31 20:42
Weekly Report: what happened at ATAI last week (0824-0828)?
Weekly Report · 08/31 10:18
Press Release: AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
Dow Jones · 08/28 18:28
SpaceX continues to be Cathie's biggest bet; trims RBLX, PLTR, and AMD
Seeking Alpha · 08/24 11:07
Weekly Report: what happened at ATAI last week (0817-0821)?
Weekly Report · 08/24 10:18
Workday, Brookfield, JetBlue, Enovix, Atai Trending With Analysts
TipRanks · 08/22 09:01
Psychedelic: Enveric, Helus, Bright Minds report earnings results
TipRanks · 08/20 15:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)
TipRanks · 08/19 16:30
Ibogaine could rise as potential psychedelic treatment with Trump announcement
Seeking Alpha · 08/18 18:14
More
Webull provides a variety of real-time ATAI stock news. You can receive the latest news about Atai Beckley Inc through multiple platforms. This information may help you make smarter investment decisions.
About ATAI
AtaiBeckley Inc is a clinical-stage biotechnology company focused on developing rapid-acting, durable and convenient mental health treatments. The Company’s pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 (R-MDMA HCI) for social anxiety disorder. The Company is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. BPL-003 is a proprietary synthetic intranasal formulation of mebufotenin benzoate being developed as a potential treatment for people living with TRD. VLS-01 is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) being developed as a potential treatment for people living with TRD. EMP-01 is an oral formulation of R-MDMA, being developed as a potential treatment for people living with social anxiety disorder.